about
Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire d...
Read More
20.44
-0.83
(-3.90%)
904.9K
XNAS Volume
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
Graphite Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..